Anti-Tumor Necrosis Factor Drug Improves CV Health in Psoriatic Arthritis
Cardiovascular health in psoriatic arthritis improves with anti-tumor necrosis factor drug etanercept.
All articles by Jeff Craven
CV Events Reduced in SLE With Aspirin and Hydroxychloroquine
Hydroxychloroquine in combination with low-dose asprin was protective against thrombosis in SLE.
CVD Risk in Type 1 Diabetes Improved With Metformin
Metformin therapy in type 1 diabetes may improved cardiovascular disease risk management.
Heart Failure Risk Increased With Fewer Menstrual Cycles
Women with fewer menstrual cycles are at a higher risk for incident heart failure.
Overweight/Obesity Affects Brain Function in Type 2 Diabetes
Overweight or obese patients with type 2 diabetes mellitus are more likely to show severe and progressive brain function and cognition abnormalities.
Nonischemic Heart Failure Risk Increased With Rheumatoid Arthritis
Researchers noted that the relative risk of heart failure increased following a patient’s RA diagnosis.
Coronary Atherosclerosis Prevalence in Psoriatic Arthritis
A large number of patients with psoriatic arthritis may have silent coronary artery disease.
Blood Pressure Dysfunction Tied to Childhood Adversity
Childhood adversity, including abuse, neglect, and low socioeconomic status, has been linked to blood pressure dysfunction from childhood into adulthood.
Sudden Cardiac Death and CHD Risks Increase With ‘Yo-Yo Dieting’
Women who experienced weight cycling had a higher risk of sudden cardiac death and coronary heart disease mortality compared with women with consistently stable weight.
Sudden Cardiac Death Risk Linked to Higher Thyroid Levels
There was a hazard ratio of 1.87 per 1-ng/dL increase of free thyroxine for patients with an increased risk of sudden cardiac death due to higher free thyroxine levels.
- Loading...
Loading...
Loading... 
Loading...